Quick Answer
UNITED THERAPEUTICS Corp reported Stockholders Equity of $7.10 billion for fiscal year 2025.
UNITED THERAPEUTICS Corp Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $7.10B | +10.1% |
| 2024 | $6.44B | +7.7% |
| 2023 | $5.98B | +24.8% |
| 2022 | $4.80B | +21.2% |
| 2021 | $3.96B | +16.6% |
| 2020 | $3.40B | +22.1% |
| 2019 | $2.78B | -0.3% |
| 2018 | $2.79B | +32.7% |
| 2017 | $2.10B | +13.5% |
| 2016 | $1.85B | +16.5% |
| 2015 | $1.59B | +27.9% |
| 2014 | $1.24B | -1.3% |
| 2013 | $1.26B | +16.2% |
| 2012 | $1.08B | +14.3% |
| 2011 | $948.49M | +7.3% |
| 2010 | $883.89M | +35.4% |
| 2009 | $653.01M | +17.6% |
| 2008 | $555.33M | +57.7% |
| 2007 | $352.13M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $6.59B | +8.0% | -8.1% |
| June 30, 2025 | $7.17B | +25.9% | +5.4% |
| March 31, 2025 | $6.81B | +27.5% | +5.6% |
| December 31, 2024 | $6.44B | +7.7% | +5.6% |
| September 30, 2024 | $6.10B | +6.8% | +7.1% |
| June 30, 2024 | $5.70B | +5.3% | +6.7% |
| March 31, 2024 | $5.34B | +4.2% | -10.8% |
| December 31, 2023 | $5.98B | +24.8% | +4.8% |
- UNITED THERAPEUTICS Corp showed an increase of +10.1% in Stockholders Equity compared to the prior fiscal year.
- Over the 2007–2025 period, UNITED THERAPEUTICS Corp’s stockholders equity has grown by 1915.2% (from $352.13 million to $7.10 billion).
- The most recent figure is from UNITED THERAPEUTICS Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: